In one paragraphArticle in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors.
Zhipeng TaoCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, United States.ORCID 0000-0002-9582-6950 Ritesh P ThakareDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, United States.ORCID 0000-0002-7426-2519 Melyssa CheungDepartment of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.
Jianan ZhangCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, United States.
Xin ChenDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, United States.
Xiaodi HuDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, United States.
Brian G PierceDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland 20742, United States.
Xu WuCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, United States.
Junhao MaoDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, United States.ORCID 0000-0003-1980-1177 Funding
Targeting dynamic palmitoylation of TEAD transcription factorsR01CA238270 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MAO, JUNHAO, WU, XU · 2019 to 2023
$2.7MChemical approach to study autopalmitoylation of transcription factorsR01DK107651 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LUO, XUELIAN, WU, XU · 2016 to 2020
$1.9MDependence for TEAD transcription factors in intestinal development and polyposisR01DK127180 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MAO, JUNHAO · 2020 to 2024
$1.9MMechanism of YAP/TAZ crosstalk with Wnt signalingR01DK127207 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MAO, JUNHAO · 2021 to 2024
$1.5MNCI NIH HHS R01 CA238270NIDDK NIH HHS R01 DK107651NIDDK NIH HHS R01 DK127180NIDDK NIH HHS R01 DK127207
6 · The paper itselfAbstract
GSDMA, the primary member of the gasdermin family found in the skin, is critical for pathogen-induced pyroptosis during infection. Recent studies revealed that another gasdermin, GSDMD, undergoes palmitoylation during pyroptosis. However, whether and how the other gasdermin members undergo lipid modification remain poorly understood. Here, we demonstrate that GSDMA is
Indexed as
Neoplasm ProteinsPyroptosisAcylationAnimalsGasderminsHumansGasderminsNeoplasm Proteins
What OpenQuestion holds
Textmetadata
Read underepoch 390